【摘要】：隨著我國中小企業(yè)的快速發(fā)展,發(fā)展過程背后隱藏的問題也日益暴露出來。目前,大部分中小企業(yè)存在短期貸款缺口大,中長期貸款成功率低,內(nèi)源性資金嚴重不足,資本結(jié)構(gòu)不合理,融資成本高等問題,導(dǎo)致短貸長投財務(wù)操作模式的興起,在目前偏緊的宏觀政策下,讓表面光鮮的上市公司存在的問題也無處可逃,短貸長投帶來的財務(wù)異化行為暴露無遺。企業(yè)財務(wù)異化,企業(yè)倒閉,老板失蹤等一系列現(xiàn)象層出不窮,基于這一背景,以北生藥業(yè)股份有限公司為研究對象,研究治理短貸長投財務(wù)異化行為。 在對企業(yè)短貸長投、財務(wù)異化行為等相關(guān)概念進行界定的基礎(chǔ)上,分別從經(jīng)濟學(xué)、管理學(xué)及行為財務(wù)學(xué)的角度闡述了企業(yè)短貸長投財務(wù)異化行為研究的理論基礎(chǔ),指出對北生藥業(yè)股份有限公司短貸長投財務(wù)異化行為治理研究的理論依據(jù),使得北生藥業(yè)短貸長投財務(wù)異化行為案例分析具有說服力。在奠定了理論基礎(chǔ)后,從北生藥業(yè)股份有限公司基本情況入手,進行定量與定性結(jié)合分析,分析為什么大部分民營企業(yè)普遍存在短貸長投現(xiàn)象,并找出引發(fā)北生藥業(yè)股份有限公司短貸長投財務(wù)異化行為的原因。接著從宏觀經(jīng)濟環(huán)境、商業(yè)銀行和公司自身三個方面剖析北生藥業(yè)股份有限公司短貸長投財務(wù)異化行為影響因素。在理論與案例分析相結(jié)合的基礎(chǔ)上,針對北生藥業(yè)短貸長投財務(wù)異化行為影響因素,通過外部融資環(huán)境的完善、商業(yè)銀行信貸管理機制的優(yōu)化和公司治理效率的提高三個方面提出解決北生藥業(yè)股份有限公司短貸長投財務(wù)異化行為問題的基本思路。 本研究對北生藥業(yè)股份有限公司短貸長投財務(wù)異化行為進行了深入系統(tǒng)的研究。通過北生藥業(yè)這一公司的具體分析研究,進而推動我國中小企業(yè)短貸長投財務(wù)異化行為深入研究,逐步完善我國企業(yè)公司治理體系以及籌融資體系。
[Abstract]:With the rapid development of small and medium-sized enterprises in China, the hidden problems behind the development process are increasingly exposed. At present, most small and medium-sized enterprises have some problems, such as large short term loan gap, low success rate of medium and long term loans, serious shortage of endogenous funds, unreasonable capital structure and high financing cost, which lead to the rise of financial operation mode of short loan and long term investment. Under the current tight macro policy, there is nowhere to escape the problems of the superficial listed companies, and the financial alienation caused by the short loan and long investment is exposed. A series of phenomena, such as enterprise financial alienation, enterprise closing down, boss missing and so on, emerge in endlessly. Based on this background, Beisheng Pharmaceutical Co., Ltd. is the research object to study the governance of financial alienation behavior of short loan and long investment. On the basis of defining the related concepts such as short loan long investment, financial alienation behavior and so on, this paper expounds the theoretical basis of financial alienation behavior of short loan long investment from the angles of economics, management and behavioral finance. It is pointed out that the theoretical basis for the study on the governance of financial alienation behavior of short loan long cast in Beisheng Pharmaceutical Co., Ltd. makes the case analysis of short loan long cast financial alienation in Beisheng Pharmaceutical Industry persuasive. After laying the theoretical foundation, starting with the basic situation of Beisheng Pharmaceutical Co., Ltd., this paper analyzes the combination of quantitative and qualitative analysis, and analyzes why most private enterprises generally have the phenomenon of short loan and long investment. And find out the cause of financial alienation behavior of Beisheng Pharmaceutical Co., Ltd. Then from the macro economic environment, commercial banks and the company itself analysis of the Beisheng Pharmaceutical Co., Ltd. short loan long investment financial alienation behavior factors. On the basis of the combination of theory and case analysis, aiming at the influence factors of financial alienation behavior of short loan and long term investment in Beisheng Pharmaceutical Industry, through the perfection of external financing environment, The optimization of credit management mechanism and the improvement of corporate governance efficiency of commercial banks put forward the basic ideas to solve the problem of financial alienation of short loan and long investment in Beisheng Pharmaceutical Co., Ltd. In this study, the financial dissimilation behavior of short loan and long investment in Beisheng Pharmaceutical Co., Ltd was studied systematically and deeply. Through the specific analysis and research of Beisheng Pharmaceutical Company, the financial alienation behavior of short loan and long investment in small and medium-sized enterprises of our country is further studied, and the corporate governance system and financing system of our country are gradually perfected.
【學(xué)位授予單位】：哈爾濱商業(yè)大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2014
【分類號】：F426.82;F406.7

【相似文獻】

相關(guān)期刊論文 前10條

1 宇靖;北生藥業(yè)股價與盈利增長反向運動[J];證券導(dǎo)刊;2004年10期

2 葉檀;;北生藥業(yè):民企上市公司圈錢游戲的典型[J];董事會;2008年12期

3 ;北生速救[J];新理財;2011年01期

4 劉勘;;再融資搶趕末班車 類別表決不該有“后門”[J];中國經(jīng)濟信息;2004年22期

5 洪海超;;關(guān)于G北生財務(wù)疑云的探討[J];今日科苑;2008年02期

6 ;精選資料庫[J];股市動態(tài)分析;2004年37期

7 鐘禾;;醫(yī)藥板塊保持可持續(xù)發(fā)展[J];資本市場;2002年09期

8 ;[J];;年期

9 ;[J];;年期

10 ;[J];;年期

相關(guān)重要報紙文章 前10條

1 廣義;北生藥業(yè)連續(xù)三年高成長[N];醫(yī)藥經(jīng)濟報;2004年

2 周邊;北生藥業(yè)　重大事項遭遇拍賣險阻[N];證券時報;2007年

3 記者 程霞;北生藥業(yè)“重生”[N];北海日報;2009年

4 習(xí)文;北生藥業(yè)：產(chǎn)品經(jīng)營資本運營比翼雙飛[N];醫(yī)藥經(jīng)濟報;2002年

5 劉元坤 劉硯華;北生藥業(yè)一批新開發(fā)的產(chǎn)品進入申報階段[N];醫(yī)藥經(jīng)濟報;2004年

6 廣義;北生藥業(yè)：期待延續(xù)“倍增效應(yīng)”[N];醫(yī)藥經(jīng)濟報;2004年

7 記者 王海洋;郡原地產(chǎn)借殼北生藥業(yè)落定[N];醫(yī)藥經(jīng)濟報;2010年

8 葉信才;北生藥業(yè)募資見效非典增利[N];中國證券報;2003年

9 東吳證券研究所;北生藥業(yè) 科技園貢獻大[N];中國證券報;2004年

10 見習(xí)記者 韋承武;北生藥業(yè)定增募資投向智慧城市[N];上海證券報;2014年

相關(guān)碩士學(xué)位論文 前1條

1 王雪玲;北生藥業(yè)股份有限公司短貸長投財務(wù)異化行為治理研究[D];哈爾濱商業(yè)大學(xué);2014年

，

本文編號：2253320